TreeFrog Therapeutics raises $75m Series B financing led by Bpifrance and announces Dr. Frederic Desdouits as CEO alongside Laurent Higueret and Peter Zippelius joining the Board of Directors
– FRANCE, Bordeaux – TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75m Series B financing round led by Bpifrance Large Venture alongside Leonard Green & Partners L.P.,